AstraZeneca PLC (STO: AZN)
Sweden
· Delayed Price · Currency is SEK 1,783.50
-4.00 (-0.22%)
Aug 30, 2024, 5:29 PM CET
AstraZeneca Revenue
AstraZeneca had revenue of $12.94B USD in the quarter ending June 30, 2024, with 13.33% growth. This brings the company's revenue in the last twelve months to $49.13B, up 10.45% year-over-year. In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth.
Revenue (ttm)
$49.13B
Revenue Growth
+10.45%
P/S Ratio
5.31
Revenue / Employee
$546.53K
Employees
89,900
Market Cap
2,774.87B SEK
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
| Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
| Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
| Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
| Dec 31, 2019 | 24.38B | 2.29B | 10.38% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB (publ) | 23.71B |
| Getinge AB (publ) | 33.33B |
| Sectra AB (publ) | 3.04B |
| Camurus AB (publ) | 1.59B |
| Vitrolife AB (publ) | 3.54B |
| Medicover AB (publ) | 21.70B |
| Elekta AB (publ) | 18.12B |
| Vimian Group AB (publ) | 3.91B |
AstraZeneca News
- 2 days ago - Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry - Benzinga
- 2 days ago - AstraZeneca share price has gone vertical; brace for a pullback - Invezz
- 3 days ago - Comparing Merck & Co With Industry Competitors In Pharmaceuticals Industry - Benzinga
- 3 days ago - We like to think UK health services aren’t influenced by big money. That’s just not true | Margaret McCartney - The Guardian
- 8 days ago - AstraZeneca Threatens To Move Vaccine Production Amid Reduced State Support - Benzinga
- 8 days ago - AstraZeneca refutes report of relocating U.K. vaccine production to U.S. - Seeking Alpha
- 8 days ago - AstraZeneca refutes report of relocating U.K. vaccine production to U.S. - Seeking Alpha
- 8 days ago - AstraZeneca warns of shifting UK vaccine production to US, FT reports - Zawya